5-BROMO-N-(2-(4-((((CYCLOHEXYLAMINO)CARBONYL)AMINO)SULFONYL)PHENYL)ETHYL)-2-METHOXY-3-PYRIDINECARBOXAMIDE
UNII LER8VF8DF8
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-bromo-n-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-3-pyridinecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LER8VF8DF8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 54916-56-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H27BrN4O5S YEHLEGUHJVOMEK-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-bromo-n-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-3-pyridinecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.